# Atovaquone

NDC: 17856-0631
Generic name: Atovaquone
Labeler / Manufacturer: ATLANTIC BIOLOGICALS CORP.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: SUSPENSION
Routes: ORAL
Marketing started: 20181011

FDA application: ANDA210692

## Active ingredients

- ATOVAQUONE: 750 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"17856-0631"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=17856-0631
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f99a8a0c-2b42-4da0-8f5a-e963fc619e8b